AVEO

AVEO Pharmaceuticals, Inc.
AVEO

Overview Fund Activity
Delisted

AVEO was delisted on the 19th of January, 2023.

Back to rankings

54 hedge funds and large institutions have $29.6M invested in AVEO Pharmaceuticals, Inc. in 2015 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 12 increasing their positions, 15 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
54
Holders Change
+5
Holders Change %
+10.2%
% of All Funds
1.46%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
12
Increased
12
Reduced
15
Closed
7
Calls
$132K
Puts
$124K
Net Calls
+$8K
Net Calls Change
+$124K

Top Buyers

1
CAM
1
Cormorant Asset Management
Massachusetts
$2.76M
2
Renaissance Technologies
2
Renaissance Technologies
New York
$3.69M
3
PC
3
PointState Capital
New York
$1.04M
4
Morgan Stanley
4
Morgan Stanley
New York
$342K
5
TC
5
TFS Capital
Pennsylvania
$295K

Top Sellers

1
ACP
1
Acuta Capital Partners
California
$0
2
California Public Employees Retirement System
2
California Public Employees Retirement System
California
$58K
3
SCM
3
Sarissa Capital Management
Connecticut
$4.03M
4
SIM
4
Spark Investment Management
New York
$211K
5
Goldman Sachs
5
Goldman Sachs
New York
$120K
Name Holding Trade Value Shares
Change 		Shares
Change %
Citigroup
51
Citigroup
New York
$1K +$1K +36 New
Manulife (Manufacturers Life Insurance)
52
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2 – – –
ACP
53
Acuta Capital Partners
California
– -$861K -59,387 Closed
Jane Street
54
Jane Street
New York
– -$109K -7,547 Closed
NCCM
55
Nine Chapters Capital Management
New Jersey
– -$94K -6,500 Closed
RFC
56
Russell Frank Company
Washington
– -$93K -6,425 Closed
CCMH
57
Cornerstone Capital Management Holdings
New York
– -$73K -5,010 Closed
D.E. Shaw & Co
58
D.E. Shaw & Co
New York
– -$50K -3,481 Closed
FMA
59
FNY Managed Accounts
New York
– -$18.1K -1,250 Closed
1 2
3